# Novartis net income entity: /record/novartis.md predicate: net_income page: /record/novartis/net_income as_of: 2026-11-09 cite: AsOf. "Novartis net income: 13,967,000,000 United States dollar", as of 2025-12-31. Claim clm_8E9D1CC51F75, https://asof.is/claim/clm_8E9D1CC51F75, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm. As of November 9, 2026, Novartis's net income on the AsOf record is $13.97 billion, dated December 31, 2025, from a primary source (sec.gov). 10 claims on Novartis's net income, 1 open and 9 superseded, each dated and sourced; a replaced value is closed with an end date, never deleted. ## Current net income What the record asserts on 2026-11-09. - [Novartis](/record/novartis.md) | net_income | 13,967,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_8E9D1CC51F75](/claim/clm_8E9D1CC51F75.md) sources: https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm ## Every dated value One claim per line, oldest first. Superseded claims stay visible. - [Novartis](/record/novartis.md) | net_income | 6,698,000,000 United States dollar | valid 2016-12-31 to 2017-12-31 | conf 0.95 | superseded | superseded_by [clm_12A2AD908EB7](/claim/clm_12A2AD908EB7.md) | [clm_A450BC25D4EC](/claim/clm_A450BC25D4EC.md) sources: https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm - [Novartis](/record/novartis.md) | net_income | 7,703,000,000 United States dollar | valid 2017-12-31 to 2018-12-31 | conf 0.95 | superseded | superseded_by [clm_86476E83D754](/claim/clm_86476E83D754.md) | [clm_12A2AD908EB7](/claim/clm_12A2AD908EB7.md) sources: https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm - [Novartis](/record/novartis.md) | net_income | 12,614,000,000 United States dollar | valid 2018-12-31 to 2019-12-31 | conf 0.95 | superseded | superseded_by [clm_0CBFF9ABD464](/claim/clm_0CBFF9ABD464.md) | [clm_86476E83D754](/claim/clm_86476E83D754.md) sources: https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm - [Novartis](/record/novartis.md) | net_income | 11,737,000,000 United States dollar | valid 2019-12-31 to 2020-12-31 | conf 0.95 | superseded | superseded_by [clm_BEA4CCA5A4E8](/claim/clm_BEA4CCA5A4E8.md) | [clm_0CBFF9ABD464](/claim/clm_0CBFF9ABD464.md) sources: https://www.sec.gov/Archives/edgar/data/1114448/000137036820000003/0001370368-20-000003-index.htm - [Novartis](/record/novartis.md) | net_income | 8,071,000,000 United States dollar | valid 2020-12-31 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_1A520E1875F6](/claim/clm_1A520E1875F6.md) | [clm_BEA4CCA5A4E8](/claim/clm_BEA4CCA5A4E8.md) sources: https://www.sec.gov/Archives/edgar/data/1114448/000137036821000006/0001370368-21-000006-index.htm - [Novartis](/record/novartis.md) | net_income | 24,018,000,000 United States dollar | valid 2021-12-31 to 2022-12-31 | conf 0.95 | superseded | superseded_by [clm_5646B015C0F8](/claim/clm_5646B015C0F8.md) | [clm_1A520E1875F6](/claim/clm_1A520E1875F6.md) sources: https://www.sec.gov/Archives/edgar/data/1114448/000137036822000010/0001370368-22-000010-index.htm - [Novartis](/record/novartis.md) | net_income | 6,955,000,000 United States dollar | valid 2022-12-31 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_9235B12B85D4](/claim/clm_9235B12B85D4.md) | [clm_5646B015C0F8](/claim/clm_5646B015C0F8.md) sources: https://www.sec.gov/Archives/edgar/data/1114448/000137036823000006/0001370368-23-000006-index.htm - [Novartis](/record/novartis.md) | net_income | 14,854,000,000 United States dollar | valid 2023-12-31 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_5BF3DA7B810B](/claim/clm_5BF3DA7B810B.md) | [clm_9235B12B85D4](/claim/clm_9235B12B85D4.md) sources: https://www.sec.gov/Archives/edgar/data/1114448/000137036824000004/0001370368-24-000004-index.htm - [Novartis](/record/novartis.md) | net_income | 11,939,000,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_8E9D1CC51F75](/claim/clm_8E9D1CC51F75.md) | [clm_5BF3DA7B810B](/claim/clm_5BF3DA7B810B.md) sources: https://www.sec.gov/Archives/edgar/data/1114448/000137036825000004/0001370368-25-000004-index.htm - [Novartis](/record/novartis.md) | net_income | 13,967,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_8E9D1CC51F75](/claim/clm_8E9D1CC51F75.md) sources: https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm ## What replaced what - $6.7 billion (2016-12-31 to 2017-12-31, [clm_A450BC25D4EC](/claim/clm_A450BC25D4EC.md)) was replaced by $7.7 billion from 2017-12-31 ([clm_12A2AD908EB7](/claim/clm_12A2AD908EB7.md)) - $7.7 billion (2017-12-31 to 2018-12-31, [clm_12A2AD908EB7](/claim/clm_12A2AD908EB7.md)) was replaced by $12.61 billion from 2018-12-31 ([clm_86476E83D754](/claim/clm_86476E83D754.md)) - $12.61 billion (2018-12-31 to 2019-12-31, [clm_86476E83D754](/claim/clm_86476E83D754.md)) was replaced by $11.74 billion from 2019-12-31 ([clm_0CBFF9ABD464](/claim/clm_0CBFF9ABD464.md)) - $11.74 billion (2019-12-31 to 2020-12-31, [clm_0CBFF9ABD464](/claim/clm_0CBFF9ABD464.md)) was replaced by $8.07 billion from 2020-12-31 ([clm_BEA4CCA5A4E8](/claim/clm_BEA4CCA5A4E8.md)) - $8.07 billion (2020-12-31 to 2021-12-31, [clm_BEA4CCA5A4E8](/claim/clm_BEA4CCA5A4E8.md)) was replaced by $24.02 billion from 2021-12-31 ([clm_1A520E1875F6](/claim/clm_1A520E1875F6.md)) - $24.02 billion (2021-12-31 to 2022-12-31, [clm_1A520E1875F6](/claim/clm_1A520E1875F6.md)) was replaced by $6.96 billion from 2022-12-31 ([clm_5646B015C0F8](/claim/clm_5646B015C0F8.md)) - $6.96 billion (2022-12-31 to 2023-12-31, [clm_5646B015C0F8](/claim/clm_5646B015C0F8.md)) was replaced by $14.85 billion from 2023-12-31 ([clm_9235B12B85D4](/claim/clm_9235B12B85D4.md)) - $14.85 billion (2023-12-31 to 2024-12-31, [clm_9235B12B85D4](/claim/clm_9235B12B85D4.md)) was replaced by $11.94 billion from 2024-12-31 ([clm_5BF3DA7B810B](/claim/clm_5BF3DA7B810B.md)) - $11.94 billion (2024-12-31 to 2025-12-31, [clm_5BF3DA7B810B](/claim/clm_5BF3DA7B810B.md)) was replaced by $13.97 billion from 2025-12-31 ([clm_8E9D1CC51F75](/claim/clm_8E9D1CC51F75.md)) ## Questions this record answers ### What is Novartis's current net income? $13.97 billion, dated December 31, 2025, from a primary source (sec.gov). The record asserts this claim as of November 9, 2026 (status valid, confidence 0.95). ### When did Novartis's net income last change? The latest value on the record is $13.97 billion, dated December 31, 2025; before it the record holds $11.94 billion, dated December 31, 2024 and closed on December 31, 2025. ### What was Novartis's net income before $13.97 billion? $11.94 billion, valid from December 31, 2024 to December 31, 2025 (status superseded), from a primary source (sec.gov). ## Read on - This page: /record/novartis/net_income (markdown: /record/novartis/net_income.md) - Entity twin: /record/novartis.md ยท timeline: /timelines/novartis.md - Every company's net income: /facts/net_income.md --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.